- Home
- KTOS vs INM Comparison
KTOS vs INM Comparison
Compare KTOS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTOS
- INM
- Stock Information
- Founded
- KTOS 1994
- INM 1981
- Country
- KTOS United States
- INM Canada
- Employees
- KTOS N/A
- INM N/A
- Industry
- KTOS Military/Government/Technical
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- KTOS Industrials
- INM Health Care
- Exchange
- KTOS Nasdaq
- INM Nasdaq
- Market Cap
- KTOS 15.3B
- INM 5.0M
- IPO Year
- KTOS 1999
- INM N/A
- Fundamental
- Price
- KTOS $90.60
- INM $1.88
- Analyst Decision
- KTOS Buy
- INM
- Analyst Count
- KTOS 14
- INM 0
- Target Price
- KTOS $78.64
- INM N/A
- AVG Volume (30 Days)
- KTOS 4.1M
- INM 104.1K
- Earning Date
- KTOS 11-04-2025
- INM 11-13-2025
- Dividend Yield
- KTOS N/A
- INM N/A
- EPS Growth
- KTOS 31.73
- INM N/A
- EPS
- KTOS 0.09
- INM N/A
- Revenue
- KTOS $1,213,100,000.00
- INM $4,942,633.00
- Revenue This Year
- KTOS $17.66
- INM N/A
- Revenue Next Year
- KTOS $18.92
- INM N/A
- P/E Ratio
- KTOS $1,054.67
- INM N/A
- Revenue Growth
- KTOS 7.76
- INM 7.50
- 52 Week Low
- KTOS $22.69
- INM $1.72
- 52 Week High
- KTOS $112.57
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- KTOS 55.20
- INM 34.36
- Support Level
- KTOS $88.26
- INM $1.80
- Resistance Level
- KTOS $93.87
- INM $2.14
- Average True Range (ATR)
- KTOS 5.09
- INM 0.10
- MACD
- KTOS -1.00
- INM -0.03
- Stochastic Oscillator
- KTOS 55.37
- INM 17.39
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.